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1. Introduction 
The transmembrane distribution of mitochondrial 
proteins has been previously studied with the non- 
penetrating, protein reagent, p-diazonium benzene 
sulfonate (DABS). Different patterns of protein 
labeling were observed in both rat liver [I] and beef 
heart [2,3] mitochondria when either the matrix or 
cytoplasmic surfaces of the inner membrane were 
exposed to DABS. The identities of the labeled 
peptides are not known. It has been reported [ 1,4] 
that electron transport activity is specifically inhibited 
in the cytochrome b-c1 region of DABS-treated 
mitochondria, possibly at the site of the oxidation 
factor [4]. In keeping with the effect of DABS on 
the cytochrome b-cl region, we have shown that 
DABS inhibits duroquinol-cytochrome c reductase 
activity in isolated Complex III [5] , but it apparently 
does not inhibit enzyme activity of isolated cyto- 
chrome oxidase [6]. Inhibition of duroquinol- 
cytochrome c reductase is, however, accompanied 
by the labeling of nearly all the peptides of isolated 
Complex III [5]. 
In the present paper we report the labeling of 
Complex III peptides in DABS-treated mitochondria 
and submitochondrial particles from beef heart. Our 
results are consistent with the labeling of the two 
core proteins [7,8] on the matrix surface of the inner 
membrane, and of a 29 000 molecular weight peptide 
on the cytoplasmic surface. 
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2. Methods 
Beef heart mitochondria, EDTA-submitochondrial 
particles [9] , Complex III [lo] , and F, -ATPase [ 1 l] 
were prepared as described. 
[35S]DABS was prepared from [35S]sulfanilic acid 
(Amersham) by the method of DePierre et al. [ 121. 
Protein labeling was carried out for 30 min at 0-4°C 
in a medium containing: l-2 mg protein/ml. 0.25 M 
sucrose, and 1.5 mM DABS (60-90 mCi/mmol). The 
reaction was stopped by addition of 72 mM histidine, 
and the protein was removed by centrifugation. The 
pellet was washed once in a buffer containing 50 mM 
Tris-HCl. pH 7.5. and 0.25 M sucrose, and was sus- 
pended in 38 mM Tris-glycine, pH 8.6. Complex III 
and Fr-ATPase were removed from the incubation 
mixture by precipitating with 50% saturated ammo- 
nium sulfate (0°C). The final pellet was dissolved in 2% 
dodecyl sulfate (SDS). 5% mercaptoethanol, and 
10 mM Tris-HCl, pH 7.5. 
Rocket immunoelectrophoresis was performed on 
DABS-labeled membranes as described [ 131. The 
precipitation lines formed against Complex III anti- 
bodies [ 131 were cut from the agarose gels and 
extracted with 2% SDS, 5% mercaptoethanol and 
10 mM Tris--HCl, pH 7.5. The extracted proteins 
were electrophoresed on polyacrylamide. gradient 
pore gels (10-2070 polyacrylamide), containing 
SDS in the system of Laemmli [14]. The gels 
were stained with coomassie blue, dried, and 
exposed to X-ray film for localization of radioactive 
peptides. 
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3. Rest&s 
Figure 1 shows coomassie blue staining (fig.1 B) 
and a~tora~ographs (fig.1 A) of mito~hon~i~ and 
submito~hondrial membranes labeled with [35S]DABS. 
For comparison the labeling patterns of isolated 
Complex III and F, -ATPase are also shown. In 
agreement with results reported for rat liver material 
[I], the labeling pattern of beef heart mitochondria 
and snbmitochond~al particles are different. In 
DABS-treated mitochondria, radioa~ti~ty is located 
predominantIy in three peptides of 29 000,44 000, 
and 70 000 molecular weight. Several minor bands 
are also present. Peptides corresponding to 29 000 
and 70 000 molecular weight are also labeled in 
isolated Complex III, whereas the 44 000 molecular 
weight peptide is not, The latter peptide is not one 
of the core proteins of Complex III as seen by its 
slightly higher mobility on SDS gels (fig.1). 
In contrast to m~to~hondria, labeling of submito- 
chondrial particles is characterized by a large number 
of more weakly labeled bands (fig.lA). The majo; 
peptide labeled in submitochondri~ particles has a 
molecular weight on SDS-polyac~lamide gels of 
29 000. The molecular weights of the other heavily 
labeled peptides (50 000 and 47 000) correspond 
A 
12 3 
~ 
Mr 
B 
4 12 3 4 
,w 9 m 1 
29.UOO - 
26.000 - 
Front - 
Fig.1. Incorporation of 35Sdiazonium benzene sulfonate into the peptides of mitochond~a nd submitochondri~ particles. 
Autoradiographs (A) and coomassie blue staining (B) of: (1) isolated Complex III, (2) mitochondria, (3) F, -ATPase and (4) sub- 
mitochondrial particles. 
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exactly to the two core proteins of Complex III [7,8] 
As expected, the 01 and /3 subunits of Fr-ATPase are 
labeled only in submitochondrial particles (fig.1 A) 
indicating that DABS does not penetrate the mem- 
brane to a significant extent during the incubation. 
As reported earlier [8], Fr-ATPase can appear as a 
contaminant in Complex III (fig.1). 
In contrast to the results of Eytan et al. [2], we 
see no evidence of labeled peptides in intact mito- 
chondria which correspond in molecular weight to 
subunits V and VII of cytochrome oxidase. Also in 
our experiments, a peptide of 70 000 molecular 
weight is heavily labeled in both Complex III and 
mitochondria, but not in submitochondrial particles. 
In Complex III this peptide is thought to be a con- 
tamination from the large subunit [ 151 of succinate 
dehydrogenase [8]. This raises a general problem, 
Mr 
A 
exemplified here with the 70 000 component in mito- 
chondria, that the labeled bands on SDS-polyacryl- 
amide gels could be composed of multiple peptides. 
The experiments reported above (fig.1) suggest 
that the major peptide labeled on the cytoplasmic 
surface of the inner membrane has a molecular weight 
of 29 000 and corresponds to one of the peptides of 
isolated Complex III. Labeling of the matrix surface, 
on the other hand, labels two peptides which corre- 
spond to the core proteins of Complex III as well as a 
peptide of 29 000. To test if these peptides are com- 
ponents of Complex III, DABS-labeled mitochondria 
and submitochondrial particles were immuno- 
precipitated with antibodies to Complex III, and the 
immunoprecipitates were electrophoresed and 
exposed to film. The results of these experiments are 
shown in fig.?. It is quite clear that the core proteins 
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Fig.2. Incorporation of “Sdiazonium benzene sulfonate into the peptides of Complex III. Autoradiographs (A) and coomassie 
blue staining (B) of: (1) Complex III immunoprecipitated from mitochondria, (2) mitochondria, (3) Complex III immuno- 
precipitated from submitochondrial particles, (4) submitochondrial particles and (5) Complex III. 
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are labeled only from the matrix side of the mem- 
brane. The 29 000 molecular weight peptide is most 
heavily labeled from the cytoplasmic side of the inner 
membrane, but weak labeling of this peptide is also 
observed in immunoprecipitates from submitochon- 
drial particles. 
4. Discussion 
The present study provides evidence that the core 
proteins of Complex III [7,8] are accessible to DABS 
only from the matrix surface of the mitochondria, 
since labeling of the peptides was observed in sub- 
mitochondrial particles but not in intact mitochon- 
dria. This asymmetry of labeling, plus the finding that 
the a! and /3 subunits of Fr-ATPase were labeled only 
in submitochondrial particles, strongly suggests that 
DABS did not penetrate the membrane to a significant 
extent during the incubation [see also l-3,6] . 
When mitochondria are labeled from the cyto- 
plasmic surface, Complex III is labeled primarily in 
the peptide of 29 000 molecular weight. It has been 
suggested [163 that his region of the SDS gel contains 
peptides of both cytochrome cr and cytochrome b. 
Since cytochrome b is thought to be a very hydro- 
phobic protein [ 171 it is tempting to suggest hat the 
peptide exposed to DABS is cytochrome cr. The 
heme-binding peptide of cytochrome cl is thought to 
be exposed on the cytoplasmic surface of the inner 
membrane [ 181. Such an assignment must, however, 
await more reliable information concerning the 
identity of the peptides in this region of the SDS gel. 
Intact mitochondria labeled with lactoperoxidase 
and “‘1 are also labeled primarily in a peptide of 
29 000 molecular weight [ 19,201 . This peptide is 
identical with the carboxyatractyloside-binding 
protein of the ATP/ADP translocator [20,21] . To 
our knowledge, no experiments have been reported 
showing that the carboxyatractyloside-binding 
protein is labeled with DABS in intact mitochondria, 
although the labeling patterns obtained with DABS 
[l, fig.11 and lactoperoxidase + “‘1 [19,20] are 
very similar. It should be mentioned, however, that 
the 29 000 molecular weight peptide is relatively 
heavily labeled in isolated Complex III treated with 
DABS [5] , whereas very little label is found in this 
peptide after treating isolated Complex III with lacto- 
peroxidase and ‘*‘I [5]. 
Treatment of intact mitochondria with DABS 
leads to inhibition of electron transport in the cyto- 
chrome b-cl region [ 1,4] . In keeping with this 
observation, we have reported that DABS inhibits 
duroquinol-cytochrome c reductase activity in 
isolated Complex III [5] . Isolated cytochrome 
oxidase is apparently not effected by treatment with 
DABS [6] . Grigolova and Konstantinov [4] postulated 
that inhibition of electron transport in the cyto- 
chrome b-c, region of DABS-treated mitochondria 
might be due to interference with the oxidation 
factor. The latter is a protein needed for electron 
transport between cytochrome b and cytochrome cr 
[2 I] , and whose molecular weight has been reported 
as 15 000 [ 161. In our experiments, however, no 
labeling of a mitochondrial peptide corresponding to 
15 000 molecular weight has been observed. An 
alternative explanation for the inhibition pattern 
produced by DABS treatment of mitochondria [4] 
could be that DABS modifies the heme-binding 
peptide of cytochrome cr directly (fig.1). and not the 
oxidation factor. 
It should be stressed that experiments such as 
those reported here can only be used to establish the 
accessibility of a particular peptide to DABS. Lack of 
labeling does not constitute proof that a peptide is 
absent from the membrane surface which has been 
treated with DABS. 
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